#
Inbrija
  • Treatments
  • Parkinson's Disease

Inbrija

Generic name:levodopa inhalation capsulesLEE-voe-DOE-pa ]
Dosage form: inhalation capsule (42 mg)
Drug class:Dopaminergic antiparkinsonism agents

Medically reviewed by Philip Thornton, DipPharm. Last updated on Mar 31, 2021.

What is Inbrija?

Inbrija is an inhaled prescription medicine used to treat symptoms of Parkinson's disease that come back (OFF episodes) while you are taking another medicine called carbidopa and levodopa.

Inbrija is not to be used in place of any medicine you take daily for Parkinson's disease.

It is not known if Inbrija is safe or effective in children.

Warnings

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

Before taking this medicine

Do not use Inbrija if you have used an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, tranylcypromine, and others.

To make sure Inbrija is safe for you, tell your doctor if you have: